Nashik: MACCIA Urges FDA To Avoid Naming Traders Before Guilt Is Established
Nashik: The Maharashtra Chamber of Commerce, Industry and Agriculture (MACCIA) has urged the Food and Drug Administration (FDA) not to publicly name or photograph traders merely on the basis of preliminary inspections or raids, before any offence is legally established. The chamber clarified that it fully supports strict legal action against those found adulterating food products or violating the…
The Maharashtra Chamber of Commerce, Industry and Agriculture (MACCIA) has requested the Food and Drug Administration (FDA) to refrain from publicly identifying or photographing traders based solely on preliminary inspections or raids, prior to any offense being legally confirmed. While MACCIA supports stringent legal measures against traders found guilty of adulterating food products or breaking regulations, the chamber warns that premature publicity could severely harm the social and business standing of merchants who may have operated honestly for many years.
A MACCIA delegation, including Branch Co-Chairperson Dipali Chandak, District Coordinator Bhavesh Manek, FMCG Committee Chairman Praful Sancheti, and other executives, met with FDA Assistant Director Mangesh Mane to present a detailed memorandum. They emphasized that an inspection or sample collection and the actual determination of wrongdoing are legally distinct.
The chamber highlighted that media reports or social media dissemination of FDA raids on specific shops, even before lab reports or further legal proceedings are finalized, can lead to misunderstandings among consumers and cause distress to traders.
MACCIA demanded that such reports must clearly state that samples have merely been sent for testing, and that any subsequent legal action will hinge on the final laboratory results. The chamber also asked that traders' identities not be revealed until an offense is legally established. If a trader is later found innocent, the chamber insists that a proportional and prominent public clarification should follow to rehabilitate the trader's tarnished reputation.
FDA Assistant Director Mangesh Mane acknowledged the memorandum and pledged that the FDA would exercise caution, ensuring fairness grounded in facts. He also invited traders to collaborate with regulatory authorities and announced an upcoming awareness seminar for them. The chamber stressed that safeguarding public health is crucial, but so is maintaining trust between honest traders and consumers.
They appealed to the FDA, media outlets, and social media users to approach such issues with sensitivity, noting that while a trader's reputation may take years to build, incorrect or incomplete reports can destroy it within hours.
Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.